Back to Results
First PageMeta Content
James A. Schlipmann Melanoma Cancer Foundation / Melanoma / Cancer organizations / AIM at Melanoma Foundation


MELANOMA PATIENTS AUSTRALIA SUBMISSION PBAC consideration of KEYTRUDA (pembrolizumab) Background of Melanoma Patients Australia (MPA) MPA is the only patient driven not for profit organisation in Australia that offers a
Add to Reading List

Document Date: 2015-02-19 18:52:21


Open Document

File Size: 264,00 KB

Share Result on Facebook
UPDATE